Geron Corp.
(NASDAQ : GERN)

( )
GERN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.38%203.941.3%$748.53m
GILDGilead Sciences, Inc.
1.09%64.130.9%$382.30m
CELGCelgene Corporation
0.44%95.681.3%$342.84m
BIIBBiogen Inc.
0.82%233.181.3%$296.36m
ILMNIllumina, Inc.
2.06%290.503.5%$291.84m
VRTXVertex Pharmaceuticals Incorporated
1.46%186.401.9%$257.84m
ALXNAlexion Pharmaceuticals, Inc.
3.06%114.842.0%$255.75m
EXASExact Sciences Corporation
-0.19%119.2324.1%$244.03m
REGNRegeneron Pharmaceuticals, Inc.
0.59%297.782.6%$212.64m
AAgilent Technologies, Inc.
1.69%72.321.6%$201.17m
SRPTSarepta Therapeutics, Inc.
-0.56%101.5014.7%$175.52m
INCYIncyte Corporation
2.34%86.072.5%$100.32m
BMRNBioMarin Pharmaceutical Inc.
2.24%78.224.3%$97.40m
GHDXGenomic Health, Inc.
0.66%74.351.8%$87.12m
IONSIonis Pharmaceuticals, Inc.
1.65%72.158.2%$82.93m

Company Profile

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.